CVS Health (NYSE:CVS) finance chief Thomas Cowhey is set to step down amid the company's ongoing turnaround efforts led by ...

CVS Health's chief financial officer, Thomas Cowhey, intends to step down, Bloomberg News reported on Monday, amid the health ...

Shares of CVS Health climbed 6.5%, to $68, in after-hours trading, while shares of UnitedHealth Group rose 6%, to $556. Spire Global reached an agreement with Kpler regarding a disputed deal for the ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News reported on ...

CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...

Although elevated after 2023 acquisitions, CVS’ financial position remains manageable, in our opinion, and investors should note that CVS intends to maintain a solid investment-grade credit rating.

Police responded to a CVS near 59th Avenue and Indian School Road around 5 p.m. for reports of a fight. When they arrived, officers found a man who had been stabbed.

Authorities say they took a 3-week-old baby into protective custody Saturday after nabbing adults who brought the child into ...

Rosie O’Donnell said she’s still reeling from Donald Trump’s infamous debate insult nearly a decade later — and revealed she left the U.S.

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...